Atopic Dermatitis Linked to Hypertension
Patients with moderate-to-severe atopic dermatitis (AD) have an increased prevalence of hypertension compared with patients who do not have AD, according to...
Cutaneous Adverse Events are Mild, Manageable for Immune Checkpoint-Treated Melanoma
Anti-CTLA4 and anti-PD1 combination immune checkpoint inhibitors are commonly used to treat melanoma, but they are associated with immune-related adverse events (AEs),...
Long-Term Treatment with Dupilumab Improves Atopic Dermatitis Symptoms
Long-term use of systemic immunosuppressants for atopic dermatitis (AD) is not recommended due to safety concerns. A long-term study of dupilumab for...
Spironolactone for Hair Loss Treatment in Breast Cancer Survivors
Spironolactone can be used off-label for androgenic alopecia; however, little is known about the safety of this treatment in breast cancer survivors,...